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pain management in tubal ligation procedures in
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Background: Vocal local (VL) is a non-pharmacological pain management technique for gynecological procedures.
In Africa, it is usually used in combination with pharmacological analgesics. However, analgesics are associated with
side-effects, and can be costly and subject to frequent stock-outs, particularly in remote rural settings. We compared
the effectiveness of VL + local anesthesia + analgesics (the standard approach), versus VL + local anesthesia without
analgesics, on pain and satisfaction levels for women undergoing tubal ligations in rural Kenya.
Methods: We conducted a site-randomised non-inferiority trial of 884 women receiving TLs from 40 Marie Stopes
mobile outreach sites in Kisii and Machakos Districts. Twenty sites provided VL + local anesthesia + analgesics
(control), while 20 offered VL + local anesthesia without additional analgesics (intervention). Pain was measured
using a validated 11-point Numeric Rating Scale; satisfaction was measured using 11-point scales.
Results: A total of 461 women underwent tubal ligations with VL + local anesthesia, while 423 received tubal
ligations with VL + local anesthesia + analgesics. The majority were aged ≥30 years (78%), and had >3 children
(99%). In a multivariate analysis, pain during the procedure was not significantly different between the two groups.
The pain score after the procedure was significantly lower in the intervention group versus the control group (by
0.40 points; p = 0.041). Satisfaction scores were equally high in both groups; 96% would recommend the procedure
to a friend.
Conclusion: VL + local anesthesia is as effective as VL + local anesthesia + analgesics for pain management during
tubal ligation in rural Kenya. Avoiding analgesics is associated with numerous benefits including cost savings and
fewer issues related to the maintenance, procurement and monitoring of restricted opioid drugs, particularly in
remote low-resource settings where these systems are weak.
Trial registration: Pan-African Clinical Trials Registry PACTR201304000495942.
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In rural sub-Saharan Africa, the provision of analgesics
during gynecological procedures can be expensive, sub-
jected to frequent stock-outs, and associated with poten-
tial side effects. Vocal local (VL) was developed as an
alternative to pharmacological approaches to pain man-
agement. In these settings, Marie Stopes International
(MSI) uses VL and local anesthesia (LA) in place of opioid* Correspondence: thoai.ngo@mariestopes.org
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reproduction in any medium, provided the oranalgesics, during “mini-laparotomy” ligation. However,
amongst other providers in African settings, standard
practice for pain management during TL is to administer
VL and LA in combination with pharmacological analge-
sics, under the assumption that VL provides inadequate
pain relief without additional analgesics.
VL has been hypothesized to increase client satisfac-
tion by reducing treatment times, giving women a more
active role, and emphasizing client-provider relation-
ships. The Vocal Local technique is a continuous process
starting from the moment the client enters the clinic,
into their consultation, procedure, recovery, through toLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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reduction, distraction from pain, and avoidance of pain.
Anxiety is minimized by having a de-medicalized envir-
onment; trained, non-judgmental staff; positive language
empowering women to manage their pain; and breathing
exercises. Distraction techniques include empathetic
continuous conversation that avoids describing the pro-
cedure, use of open-ended questions, and structured em-
pathetic attention to help the client manage the pain in
the event that she cannot take her attention away from
it. Pain is avoided through the use of gentle clinical tech-
niques with non-rigid instruments, and non-use of uter-
ine elevators. However, the effectiveness of VL has not
been rigorously evaluated. Evidence shows that a pleas-
ant de-medicalized environment and friendly staff in-
crease client satisfaction [1,2]. Some studies suggest that
distraction techniques reduce pain when used in adjunct
to analgesics during acute pain and surgical procedures
[3-5]; but their effectiveness as a substitute for analgesics
has not been assessed. Some evidence suggests that em-
pathetic attention reduces pain, anxiety, need for drugs
and procedure time [6], yet other studies showed it hin-
ders patients’ ability to cope with the pain [7]. While one
study found that relaxation reduced pain following
gynecological surgery [8], a review [9] showed that
rhythmic breathing (used in VL) was not effective. An-
other review evaluating relaxation as the sole analgesic
found limited evidence that relaxation was an effective
form of pain relief [10].
The existing literature has examined non-pharmacological
techniques as a supplement rather than a substitute to
analgesics, and as separate components rather than a
package (which may alter their effectiveness). Many of
these studies had small sample sizes, and most were
conducted in urban or hospital settings rather than
low-infrastructure rural clinics. We conducted a non-
inferiority study to evaluate the effectiveness and ac-
ceptability of the VL package as a substitute for
pharmacological pain relief during TL in rural settings.
Methods
A site-randomized controlled non-inferiority study was
conducted to compare the effect of VL and local
anesthetic (VL + LA) versus VL + LA + analgesics, on
pain and satisfaction in women undergoing TL in rural
Kenya. The local anesthetic consisted of 2% lignocaine,
while the analgesic consisted of 50 mg of Tramadol
Hydrochloride (an opioid). The objective was to test
whether VL + LA provide at least equivalent pain relief
as the standard approach of using VL + LA with pharma-
cological analgesics. This study was approved by the
Ethics Review Committee at MSI and the in-country
Ethics Review Committee at Kenyatta National Hospital,
Nairobi, Kenya.The study was conducted from 6th February to 14th
July 2012 in 40 MSI mobile outreach clinics in rural
Kisii, Nyamira, Machakos, Kitui, Makueni and Kajiado
counties, Kenya. MSI delivers TL via mobile outreach
teams working with national family planning programs,
providing low infrastructure facilities with the equip-
ment and skills necessary for the procedures. Women
aged ≥18 opting for TL at participating clinics during
the study period were informed about the study’s aims,
confidentiality agreements, their right to not participate
or to put any questions they wanted, and were asked for
their consent to participate. Their response was recorded
on the consent form, the interviewer signed next to it
and showed the client (clients did not sign themselves as
many are illiterate), and each participant was given an
information sheet to take home. Clients were then
screened for medical eligibility to undergo the proced-
ure, following routine protocol for tubal ligations. Indi-
viduals with uncontrolled epilepsy, renal impairment,
hypotension, recent head injury and sexually transmitted
infections were excluded from the study.
The VL technique was standardized across study sites
by including only MSI mobile outreach clinics, where
providers received the same training. Clinics were di-
vided into two groups: control sites (using VL + LA + an-
algesics) and intervention sites (using VL + LA). Half of
the clinics (n = 20) located in Kisii, Nyamira and Macha-
kos belonged to the intervention group, while the other
20 clinics in Kitui, Makueni and Kajiado were in the
control group. Two outreach teams, consisting of a doc-
tor and a nurse experienced in TL and an assistant spe-
cialized in VL, served each study group, and all
underwent the same training; having more than one
team serving each group ensured that differences be-
tween groups were not due to a particular provider’s
experience and characteristics. The VL assistants re-
ceived intensive training in VL when they first started
in the mobile outreach TL team, as well as refresher
training before the start of the study. All assistants
were highly trained and experienced in delivering the
technique.
Women attending control sites received VL + LA (con-
sisting of 10ml of 2% lignocaine), coupled with 50 mg of
Tramadol Hydrochloride (an opioid analgesic) injected
intramuscularly thirty minutes prior to the procedure.
VL + LA + analgesics is the standard pain management
approach for TL in most African settings outside MSI
clinics. In the intervention clinics, women were offered
VL and LA without any additional analgesics. Since (in
contrast to other providers) the MSI standard is to use
VL + LA without analgesics (the “intervention” treat-
ment), the study did not withhold any standard treat-
ment in the intervention clinics, and women were
informed that they would not receive an analgesic
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trol” clinics, women were offered the MSI treatment
(VL + LA) as well as an analgesic, which is the standard
package offered by other (non MSI) tubal ligation
providers.
After being discharged, all eligible women were invited
to complete a face-to-face structured questionnaire with
their informed consent. To minimize biases, the inter-
view was administered outside the clinic by non-MSI
staff. The main outcomes were pain during the proced-
ure as a whole, pain at the most painful moment of the
procedure (which was determined by each woman indi-
vidually, and could be any time between entering and
exiting the procedure room), pain after the procedure,
and satisfaction with the procedure. Pain was measured
using the 11-point Numeric Rating Scale (NRS), a visual
scale from 0 (no pain) to 10 (extreme pain). The NRS
has been extensively validated [11,12], including in the
context of acute gynecological pain and in low-resource
settings [13,14], showing high acceptability [15-17], reli-
ability [15,16], sensitivity [12], response rate [16], and
low error rates [17]. Satisfaction was measured using an
11-point numeric scale, Likert-type scales and pre-coded
categorical response questions. Secondary outcomes in-
cluded anxiety during the procedure, experience of side
effects, and treatment time.
As this was a non-inferiority study, the sample size
was determined based on how much higher the pain
score in the intervention group would have to be to
show that VL + LA should not be used without analge-
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Figure 1 Study cohort profile.combination with physiological measures of pain have
shown that the minimum clinically relevant difference in
pain is around 1.3 [18,19]. The standard deviation (SD)
of pain scores during gynecological procedures tends to
fall within the range of 3–3.5 using an 11-point scale
[20,21]. Assuming a SD of 4 and a design effect of 2 to
account for clustering at the clinic level, the sample size
required to detect a difference of 1.3 in pain scores be-
tween groups was 326 per group, with 90% power at the
5% significance level. This was increased to 500 to allow
for a design effect larger than 2.
Analyses were performed in STATA 12 (StataCorp,
College Station, TX, USA). Results were adjusted for
clustering at the clinic level. After examining crude dif-
ferences between groups, multivariate linear regression
was used to measure the difference in pain and satisfac-
tion scores between groups, controlling for women’s
characteristics. Because women had to retrospectively
evaluate their pain during the procedure, pain reporting
may vary with time elapsed between procedure and
interview, so this was controlled for.
Results
All women attending the clinics for TL during the re-
cruitment period consented to participate in the study;
after screening, 61 women were ineligible for medical
reasons (Figure 1). Recruitment stopped when the target
sample size of 500 in each group was reached. Of 1,000
women, 77 in the control group and 39 in the interven-
tion group did not complete the survey, citing time con-
straints. In total, 889 women completed interviews: 423attending 
eriod
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Table 1 Characteristics of women undergoing tubal ligation, by control and intervention groups
VL + LA + analgesics (control) N = 423 VL + LA only (intervention) N = 461 p-valuea
Socio-demographic characteristics % (n) % (n)
Age group
<25 3.09 (13) 1.74 (8)
25-29 18.53 (78) 20.61 (95)
30-34 41.57 (175) 38.61 (178)
35+ 36.82 (155) 39.05 (180) p = 0.469
Marital status
Married 95.97 (405) 96.53 (445)
Not married 4.03 (17) 3.47 (16) p = 0.690
Educational level
None 1.90 (8) 2.39 (11)
Primary 62.23 (262) 63.56 (293)
Secondary 35.15 (148) 32.32 (149)
College 0.71 (3) 1.74 (8) p = 0.607
Area of residence
Urban/semi-urban 12.80 (54) 10.41 (48)
Rural 87.20 (368) 89.59 (413) p = 0.565
Occupation
Unemployed 13.70 (57) 17.94 (82)
Agriculture 37.50 (156) 40.70 (186)
Manual 47.60 (198) 38.95 (178)
Third Sector 1.20 (5) 2.41 (11) p = 0.266
Number of births
1-2 1.18 (5) 1.08 (5)
3-4 39.01 (165) 39.26 (181)
5-6 43.50 (184) 46.20 (213)
7+ 16.31 (69) 13.45 (62) p = 0.704
TL related characteristics
Who made decision for TL uptake
Respondent 14.18 (60) 14.10 (65)
Partner 1.18 (5) 1.95 (9)
Jointly with partner 84.16 (356) 83.08 (383)
Others (eg family) 0.47 (2) 0.87 (4) p = 0.789
Had counselling about TL before
No 46.68 (197) 45.65 (210)
Yes 53.32 (225) 54.35 (250) p = 0.877
Travel time from home to facility
<1 hour 49.29 (208) 44.69 (206)
1-2 hours 46.92 (198) 52.06 (240)
3+ hours 3.79 (16) 3.25 (15) p = 0.607
Waiting time at outreach facility
<1 hour 3.79 (16) 3.47 (16)
1-2 hours 31.28 (132) 31.02 (143)
3-4 hours 42.42 (179) 48.81 (225)
5+ hours 22.51 (95) 16.70 (77) p = 0.466
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Table 1 Characteristics of women undergoing tubal ligation, by control and intervention groups (Continued)
Anxiety level when entering facility
Not at all anxious 79.62 (336) 83.51 (385)
A little bit anxious 17.06 (72) 13.45 (62)
Anxious 2.61 (11) 1.30 (6)
Very anxious 0.71 (3) 1.74 (8) p = 0.298
ap-value for Chi-square.
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vention group.
The majority of respondents were over 30 (78%), mar-
ried (96%) with 3 or more children (99%). There were
no differences between the two groups in socio-
demographic characteristics or time between the end
of the procedure and the interview (~24 minutes)
(Table 1).
Women reported pain levels ranging from 0 to 10 on
the three different measures: pain during the procedure,
pain at the most painful moment of the procedure, and
pain at the time of interview, with medians between 6
and 8. The spread of scores was widest for pain at the time
of interview [±SD = 2.11; interquartile range (IQR) = 4],
and narrowest for pain at the most painful moment
[±SD= 1.73; IQR = 2]. Scores displayed a normal distribu-
tion with a slight negative skew (between −0.32 and −0.08)
for each of the three measures (Table 2).
Satisfaction scores ranged from 1 to 10 on all four of
the measures (Table 3). Over 90% of respondents chose
10 out of 10 on each measure, resulting in strong nega-
tive skews between −5 and −7. Over 25% of women ex-
pected the visit to be shorter, while 8% felt worse than
expected after the procedure.
Bivariate analyses showed no significant differences be-
tween groups in pain and anxiety (Table 2). The propor-
tion of women reporting side effects during the procedure
and at the time of interview did not vary by study group,
except for fever at the time of interview, which was more
prevalent among women in the intervention group
(31% vs. 15%; p = 0.015). The two groups had similar mean
satisfaction scores above 9.7, and median scores of 10. A
higher proportion of women in the intervention group than
the control group reported that their consultation was
private (99.6% vs. 96.7%; p = 0.006), and that they felt com-
fortable during the procedure (100% vs. 98.1%; p = 0.035)
(Table 3).
In a multivariate linear regression adjusting for socio-
demographic and other personal characteristics related
to TL (Table 4), the intervention group had non-
significantly lower pain scores than the control group
during the procedure as a whole and at the most painful
moment. After adjusting for other factors, mean pain at
the time of interview was significantly lower in theintervention (VL + LA) group than the control group, by
0.40 points [95% CI: 0.02-0.78].
Other covariates were significantly associated with
pain scores in the overall study population: women who
were anxious about the procedure experienced greater
pain during the procedure and at their most painful
moment than those who were not at all anxious.
Women with no education reported less pain at the
time of interview than those with primary education.
Women in manual jobs reported less pain than those
who were unemployed or in agriculture, on all three
measures.
All women consented to TL voluntarily at the clinics;
however, women who reported that it was primarily
others (partner/family) who had decided they should
have a TL reported far greater pain (~3 points higher)
than those who had decided on their own (p = 0.002).
Pain decreased with increasing recovery time between
procedure and interview (p < 0.001).
The multivariate analysis found no differences in satis-
faction scores between study groups. Satisfaction in-
creased significantly with increasing recovery time
between procedure and interview (p = 0.039); and
women who had travelled further to the clinic reported
lower satisfaction (p = 0.034).
Discussion
In this non-inferiority study, we showed that VL + LA
was as effective on its own as with pharmacological anal-
gesics in managing pain during TL in rural Kenya. After
adjusting for other factors, pain during the procedure
was not significantly different between the two groups,
while pain at the time of interview was significantly
lower in the group that did not receive analgesics (inter-
vention). This might be explained by the analgesics
wearing off in the control group by the time of the inter-
view (leading to increased pain). The analgesic did not
appear to reduce pain even at the most painful moment
when administered in addition to VL.
Although women’s characteristics did not differ signifi-
cantly between intervention and control groups, they
were nonetheless adjusted for in the multivariate models.
There may however be differences between groups that
were not measured and adjusted for (i.e. at the county
Table 2 Pain and anxiety experienced by women in control and intervention groups
VL + LA + analgesics (control) N = 423 VL + LA only (intervention) N = 461 p-valuea
Relaxation when lying waiting (%)
Very relaxed 46.34 40.78
Relaxed 44.21 48.16
Not really relaxed 8.98 9.33
Not relaxed at all 0.47 1.74 p = 0.520
During procedure
Anxiety during procedure (%)
Not anxious at all 35.93 34.06
A little bit anxious 56.74 57.70
Anxious 4.49 5.86
Very anxious 2.84 2.39 p = 0.849
Pain intensity compared to expected (%)
Less than expected 31.44 31.24
As expected 42.32 42.52
More than expected 26.24 26.25 p = 0.995
Moment pain was most intense (%)
Cutting/opening of abdomen 1.18 1.08
Hooking/insertion of instrument 96.93 97.61
Closing/stitching 1.89 1.30 p = 0.801
Percent reporting pain was too much 8.04 6.29 p = 0.573
Percent experiencing any side effect 5.44 3.69 p = 0.376
Drowsiness 4.55 0.00 p = 0.440
Dizziness 36.36 20.00 p = 0.398
Nausea/vomiting 13.64 33.33 p = 0.113
Pain elsewhere 27.27 26.67 p = 0.965
Fast heartbeat 9.09 0.00 p = 0.257
Fever 22.73 33.33 p = 0.443
Mean pain scores (SD)
Mean score overall 6.63 (1.81) 6.46 (1.94) p = 0.172
Mean score during most painful moment 7.00 (1.68) 6.88 (1.77) p = 0.467
After procedure
Mean pain score at interview (SD) 5.58 (2.14) 5.23 (2.07) p = 0.091
Percent still experiencing any side effect 23.64 23.43 p = 0.940
Drowsiness 9.00 4.63 p = 0.272
Dizziness 39.00 27.78 p = 0.230
Nausea/vomiting 37.00 33.33 p = 0.672
Pain elsewhere 31.00 34.26 p = 0.538
Fast heartbeat 0.00 0.93 p = 0.331
Fever 15.00 31.48 p = 0.015
Difficulty breathing 0.00 0.93 p = 0.308
ap-value for Chi-square test for proportions; p-value for t-test for mean pain scores.
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outcome measures, the NRS for pain has been validated
in some African settings, but not specifically in Kenya.Kenyan women may have a different understanding of
pain relative to women in Western settings (where the
scale has mainly been used). Pain scores displayed a
Table 3 Satisfaction measures for women in control and intervention groups
VL + LA+ analgesics (control) VL + LA only (intervention) p = valueb
Satisfaction scores (SDa)
Mean satisfaction with procedure 9.83 (0.76) 9.77 (0.90) p = 0.484
Mean satisfaction with health provider 9.88 (0.67) 9.84 (0.69) p = 0.549
Mean satisfaction with care after procedure 9.85 (0.73) 9.87 (0.67) p = 0.811
Mean satisfaction with length of visit 9.72 (1.10) 9.81 (0.78) p = 0.329
Length of visit compared to expected (%)
Longer 29.55 26.90
About the same 40.19 38.18
Shorter 30.26 34.92 p = 0.687
Procedure length compared to expected (%)
Longer 4.27 1.97
About the same 8.29 6.55
Shorter 87.44 91.48 p = 0.329
Well-being at time of interview (%)
Very well 19.39 17.79
Well 64.07 70.07
Neither well nor unwell 11.11 9.33
Not too well 5.20 2.60
Not well at all 0.24 0.22 p = 0.512
Well-being at interview compared to expected (%)
Better 41.61 42.95
As expected 50.12 48.81
Worse 8.27 8.24 p = 0.947
Consultation was private (%) 96.69 99.57 p = 0.006
Procedure performed privately (%) 98.58 99.78 p = 0.082
Would have liked more information (%) 85.82 85.90 p = 0.989
Felt comfortable during procedure (%) 98.10 100.00 p = 0.035
Would recommend this clinic to a friend (%)
Yes 95.51 96.10
No 1.18 0.65
Unsure 3.31 3.25 p = 0.743
Mean treatment time in mins (±SD) 6.03 (3.35) 5.44 (2.58) p = 0.228
aSD = standard deviation; bp-value for t-test for difference.
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stood by respondents.
In contrast, the satisfaction scale exhibited a strong
negative skew due to heavy rating of the high scores,
questioning its validity. Clients’ satisfaction with health
services has been a difficult concept to measure [22],
and this may be exacerbated in settings where strong
hierarchical relationships prevail between patient and
provider. We minimized this issue by using non-MSI
interviewers. Different scales should be developed to ob-
tain more sensitive satisfaction measures. The interven-
tion group’s greater satisfaction on certain aspects of
their experience (private consultation, comfort duringthe procedure) calls for further investigation into the
implementation of VL. Ensuring that consultations
are private and that women feel comfortable are in-
trinsic components of VL. However, VL should have
been implemented comparably in both groups, and
the use of analgesics should not have affected these
outcomes.
Previous studies [3-5,8,23,24] showed that relaxation
and distraction techniques help reduce pain during sur-
gical procedures. This is the first study to evaluate VL as
a package and a substitute for pharmacological analge-
sics in a rural African mobile outreach setting. Going be-
yond findings from hospital settings, this study provides
Table 4 Adjusteda differences in mean scores of pain and satisfaction




Control (ref ) 0.00 0.00 0.00 0.00
Intervention -0.23 (-0.50-0.03) -0.17 (-0.42-0.07) -0.40 (-0.78–0.02)* -0.06 (-0.18-0.06)
Marital status
Married (ref ) 0.00 0.00 0.00 0.00
Not married -0.04 (-0.87-0.94) 0.18 (-0.47-0.84) 0.80 (-2.05-0.44) 0.18 (-0.05-0.40)
Educational level
None -0.25 (-1.31-0.82) -0.15 (-0.95-0.65) -1.32 (-2.22–0.42)° -0.32 (-0.88-0.24)
Primary 0.00 0.00 0.00 0.00
Secondary -0.04 (-0.27-0.19) -0.12 (-0.39-0.14) 0.14 (-0.16-0.44) 0.06 (-0.06-0.19)
College 0.86 (-0.35-2.08) 0.35 (-0.58-1.29) 0.66 (-0.83-2.15) 0.23 (-0.01-0.47)
Area of residence
Urban/semi-urban 0.00 0.00 0.00 0.00
Rural 0.14 (-0.31-0.58) -0.04 (-0.37-0.30) 0.29 (-0.14-0.73) -0.06 (-0.14-0.26)
Occupation
Unemployed 0.65 (0.08-1.22)* 0.84 (0.29-1.41)° 0.73 (0.15-1.31)* -0.23 (-0.44–0.02)*
Agriculture 1.23 (0.87-1.60)+ 1.04 (0.70-1.42)+ 1.67 (1.23-2.11)+ 0.18 (-0.07-0.28)+
Manual 0.00 0.00 0.00 0.00
Third sector 0.03 (-1.45-1.51) 0.84 (-0.09-1.74) 0.49 (-0.73-1.71) 0.01 (-0.34-0.36)
Number of births
1-2 0.54 (-0.28-1.37) 0.35 (-0.27-1.04) 0.82 (-0.35-1.99) -0.26 (-0.93-0.40)
3-4 0.27 (0.01-0.54)* 0.20 (-0.05-0.45) 0.09 (-0.19-0.36) -0.01 (-0.14-0.11)
5-6 0.00 0.00 0.00 0.00
7+ 0.34 (-0.04-0.72) 0.20 (-0.16-0.56) 0.31 (-0.09-0.71) -0.11 (-0.28-0.06)
TL related characteristics
Who made decision for TL uptake
Respondent 0.00 0.00 0.00 0.00
Partner 0.58 (-0.70-1.86) 0.38 (-0.77-1.54) 0.33 (-0.62-1.27) -0.40 (-1.35-0.34)
Jointly with partner -0.22 (-0.64-0.20) -0.42 (-0.80–0.03)* 0.14 (-0.32-0.60) 0.08 (-0.13-0.29)
Others (eg family) -0.78 (-2.41-0.86) -0.20 (-1.92-1.52) 2.86 (1.08-4.64)° 0.28 (-0.29-0.85)
Mean time to clinic - increase for each
hour increase in time to clinic





















Table 4 Adjusteda differences in mean scores of pain and satisfaction (Continued)
Mean time between procedure and
interview (for each minute increase)
Not relevant to model Not relevant to model -0.01 (-0.02–0.01)+ >0.00 (0.00-0.00)*
Anxiety level when entering clinic
Not at all anxious 0.00 0.00 0.00 0.00
A little bit anxious 0.71 (0.30-1.13)+ 0.62 (-0.31-0.96)+ 0.37 (-0.03-0.77) 0.01 (-0.15-0.17)
Anxious 0.74 (0.12-1.36)* 0.71 (-0.09-1.44) -0.02 (-0.90-0.85) 0.07 (-0.26-0.40)
Very anxious -0.02 (-1.75-1.70) -0.25 (-1.79-1.33) -0.56 (-2.34-1.21) 0.14 (-0.24-0.52)
+p≤0.001; °0.001 < p≤0.01; *0.01 < p≤0.05.
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gesics, specifically in rural low-resource facilities where
replacing analgesics with non pharmacological treatments
could lead to significant cost savings and more efficient
services. The effectiveness of VL is dependent on high
quality provider training: providers had been using VL
daily for several years with regular refresher training, and
it is uncertain what effect the intervention would have had
on pain had providers been less experienced. Further re-
search should examine how the use of VL without analge-
sics can be standardized and rolled out beyond MSI
mobile clinics to other healthcare settings and service de-
livery models.
The potential benefits of using VL without additional
analgesics are numerous. It can reduce the risk of med-
ical error and side effects associated with opioid drugs.
Drowsiness from analgesics can lead to longer clinic
stays, when many women may prefer a shorter visit. The
VL + LA approach would eliminate issues related to the
maintenance, procurement and monitoring of restricted
opioid drugs, particularly in low-resource settings where
such systems are weak. Drug stock-outs in remote set-
tings can delay the procedure or prevent women from
having it, which could result in unwanted pregnancies.
Employing the low-cost VL technique could lead to sub-
stantial savings in settings like Kenya where resources
are scarce. If cost-effective, VL could potentially be used
as a substitute for analgesics during other ob/gyn proce-
dures, such as caesarean sections. Policy recommenda-
tions regarding the wider adoption of VL without
analgesics for TL and other procedures should be based
on the cost-effectiveness of each approach, using a wider
health systems approach.
Caution should be used in generalizing the results of
this study to other rural African settings, larger health
facilities and urban areas. Women using mobile out-
reach clinics for TL may exhibit different characteristics
to those seeking services at formal health facilities. The
VL + LA approach might be well suited to certain pop-
ulations, while it may be inferior to pharmacological
pain relief in other populations. Women in this study
did display similar characteristics to those seeking TLs
in other healthcare settings in Kenya [25]. However, it
is possible that women in other settings might have dif-
ferent expectations regarding pain management, which
may in turn impact their pain tolerance. For example,
in certain formal health facilities in Kenya, and in
health facilities in other countries, standard practice for
tubal ligation may involve an analgesic local anesthetic,
and it may be unimaginable for women to go without
it. Thus, women’s expectations regarding the treatment
they will receive and the amount of pain they will en-
dure may affect the level of pain they experience. For
this reason, we must be cautious in generalizing theseresults to other settings where anesthesia is the norm
and expectation for tubal ligation.
Conclusion
This study is the first to evaluate the VL pain manage-
ment technique as a package for use as a substitute for
pharmacological analgesics in gynecological procedures.
The findings provide strong evidence that VL + LA is as
effective on its own as with additional analgesics for mo-
bile outreach TL services in rural Kenya. Using VL + LA
could lead to significant cost savings and more efficient
services, particularly in rural low-resource settings.
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